On Oct 18, major Wall Street analysts update their ratings for $Equifax (EFX.US)$, with price targets ranging from $293 to $380.
Goldman Sachs analyst George Tong maintains with a hold rating, and adjusts the target price from $307 to $293.
Barclays analyst Manav Patnaik maintains with a buy rating, and maintains the target price at $380.
Wells Fargo analyst Jason Haas CFA maintains with a buy rating, and adjusts the target price from $375 to $350.
Oppenheimer analyst Owen Lau maintains with a buy rating, and maintains the target price at $315.
Needham analyst Kyle Peterson maintains with a buy rating, and maintains the target price at $350.
Furthermore, according to the comprehensive report, the opinions of $Equifax (EFX.US)$'s main analysts recently are as follows:
Equifax's third-quarter results were characterized as 'mixed,' with reported revenue and EBITDA margins slightly below estimates and consensus. Notably, a positive development emerged as mortgage inquiries during the third quarter showed year-over-year growth for the first time since 2021. This suggests a potential bottoming out of mortgage volumes, which could experience ongoing benefits from lower interest rates.
The firm considers the recent guidance reduction a modest negative, yet believes the company is on the brink of a significant multi-year period of earnings growth. The valuation is seen as appealing when adjusted for the mortgage cycle, and the company stands as the leading stock idea within the consumer credit information sector.
Here are the latest investment ratings and price targets for $Equifax (EFX.US)$ from 6 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美東時間10月18日，多家華爾街大行更新了$艾可菲 (EFX.US)$的評級，目標價介於293美元至380美元。
高盛集團分析師George Tong維持持有評級，並將目標價從307美元下調至293美元。
巴克萊銀行分析師Manav Patnaik維持買入評級，維持目標價380美元。
富國集團分析師Jason Haas CFA維持買入評級，並將目標價從375美元下調至350美元。
奧本海默控股分析師Owen Lau維持買入評級，維持目標價315美元。
Needham分析師Kyle Peterson維持買入評級，維持目標價350美元。
此外，綜合報道，$艾可菲 (EFX.US)$近期主要分析師觀點如下：
艾可菲的第三季度業績被描述爲「融合」，報告的營業收入和EBITDA利潤率略低於預期和共識。值得注意的是，一個積極的發展是第三季度按揭諮詢首次自2021年以來出現了同比增長。這表明按揭量可能觸底，從較低的利率期貨中獲益的潛力將持續存在。
公司認爲最近的指引調低是一種輕微的負面，但認爲該公司正處於一個重要的多年盈利增長期的邊緣。從按揭週期調整後，估值被認爲是有吸引力的，公司是消費信用信息板塊的領先股票推薦。
以下爲今日6位分析師對$艾可菲 (EFX.US)$的最新投資評級及目標價：
提示:
TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。
TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。
分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。
總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。
